Sands Capital Life Sciences Pulse Fund II, L.P.

13F Holdings History for Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (ACRV)

Symbol: ACRV on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 2.12M shares
Security Ownership: 6.8%

Sands Capital Life Sciences Pulse Fund II, L.P. ownership in Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (ACRV)

2025-08-13 - Sands Capital Life Sciences Pulse Fund II, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.12M shares of Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (ACRV). This represents 6.8% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Sands Capital Life Sciences Pulse Fund II, L.P.	6.8%		$2.82M	2.12M			$1.33	13G/A	6/30/2025	13 Aug 2025 11:12:23